Dementia and Alzheimer Disease

Epilepsy

Migraine

Headache and Migraine

MS Advanced Practice Providers

Multiple Sclerosis

NMOSD

MS and Demyelinating Disorders

Parkinson Disease

Movement Disorders

Ataxia

Chronic Inflammatory Demyelinating Polyneuropathy

Muscular Dystrophy

Neuromuscular

Insomnia

Narcolepsy

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Medcast

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

Bridging the Gaps

International Journal of MS Care

Resources

Expert Authors

FDA News

Features

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

Articles

Over a 52-week treatment period, patients who continued on bexicaserin and those who switched from placebo demonstrated notable decreases in motor seizures, further supporting the agent’s development.

New Open-Label Data Highlights Therapeutic Potential of Bexicaserin in Developmental and Epileptic Encephalopathies

Videos

In this episode, women neurologists share their personal experiences navigating challenges in neurology, offering insights into mentorship, work-life balance, and career advancement.

Episode 3: Overcoming Challenges as a Woman in the Medical Workforce

The movement disorder specialist and director of Integrative Neurosciences at Allegheny Health Network discussed key advancements in the field of neurology for 2025. 

NeuroVoices: Sushma Kola, MD, on Integrative Approaches and Research Developments for Neurology Care in 2025

Catch up on any of the neurology news headlines you may have missed over the course of January 2025, compiled all into one place by the NeurologyLive® team.

FDA Action Update, January 2025: Approvals, Clearances, and Designations

Marco Meglio, Assistant Managing Editor for 

, has been with the team since October 2019. Follow him on Twitter 

A group of empowering women leaders in neurology explore the transformative impact of women neurologists on the medical workforce and the strides toward a more inclusive neurology field.

Episode 2: Innovative Policies That Advance Women in Neurology Departments

Deborah Benzil, MD, FAAS, vice chair of neurosurgery at Cleveland Clinic's Center for Spine Health, shared her extraordinary journey of resilience, from overcoming repeated rejections to becoming a trailblazer for women in neurosurgery, and reflects on the progress made and the challenges that remain.

Finding Happiness as a Trailblazer

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

LinkedIN

YouTube

Spotlight

AES 2024

ISC 2025

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

Data into Action: Incorporating research into treatment decisions with eptinezumab

Innovation in “On” time is here: Introducing CREXONT<sup>®</sup> (carbidopa and levodopa) extended-release capsules

Introducing a New Indication for VYVGART<sup>®</sup> Hytrulo

Putting the Pieces Together: Cervical Dystonia Diagnosis, Comorbidities, and Treatment

Interactive Tools

Data into Action: Incorporating research into treatment decisions with eptinezumab

Innovation in “On” time is here: Introducing CREXONT^® (carbidopa and levodopa) extended-release capsules

Introducing a New Indication for VYVGART^® Hytrulo

Putting the Pieces Together: Cervical Dystonia Diagnosis, Comorbidities, and Treatment

Interactive Tools

Data into Action: Incorporating research into treatment decisions with eptinezumab

Innovation in “On” time is here: Introducing CREXONT® (carbidopa and levodopa) extended-release capsules

Introducing a New Indication for VYVGART® Hytrulo

Putting the Pieces Together: Cervical Dystonia Diagnosis, Comorbidities, and Treatment

Innovation in “On” time is here: Introducing CREXONT^® (carbidopa and levodopa) extended-release capsules

Introducing a New Indication for VYVGART^® Hytrulo